NDC codes

FDA NDC Directory
Product NDC (as listed)72162-2038Labeler and product segments. Claims need a package NDC.
Product NDC at billing width72162-2038Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
72162-2038-272162203802473 mL in 1 BOTTLE (72162-2038-2)Marketed from Jun 6, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Theophylline
Generic name (nonproprietary)
theophylline
Active ingredients
Theophylline anhydrous — 80 mg/15mL
Dosage form
Solution
Route
Oral
Labeler
Bryant Ranch PrepackNDC labeler code 72162
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 091586
Marketing start
Listing expires
Other FDA classes
Xanthines (Chemical structure)
Identifiers
Product ID 72162-2038_601b3954-8a02-425f-abb9-100069663c9aSPL ID 601b3954-8a02-425f-abb9-100069663c9aSPL set ID 955dba5e-c3b7-4a45-8650-e1b4722dbaeaRxCUI 313306UNII 0I55128JYK
Pharmacologic class
Methylxanthine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472162203802 followed by a unit qualifier and the quantity

Package 72162-2038-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INDICATIONS AND USAGE Theophylline oral solution is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 72162-2038

What is NDC 72162-2038?
72162-2038 is the product NDC for Theophylline, Theophylline anhydrous 80 mg/15mL solution, listed with the FDA by Bryant Ranch Prepack. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Theophylline.
What is the active ingredient?
Theophylline anhydrous.
Who is the labeler?
Bryant Ranch Prepack, NDC labeler code 72162. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Theophylline?
40 other product NDCs are listed under this name. See all Theophylline NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Theophylline NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
TheophyllineTheophylline anhydrous 300 mg/1Tablet, Extended releaseOralAjanta Pharma USA Inc.27241-27227241-0272-01
TheophyllineTheophylline anhydrous 450 mg/1Tablet, Extended releaseOralAjanta Pharma USA Inc.27241-27327241-0273-01
TheophyllineTheophylline anhydrous 300 mg/1Tablet, Extended releaseOralStrides Pharma Science Limited64380-24364380-0243-01
TheophyllineTheophylline anhydrous 450 mg/1Tablet, Extended releaseOralStrides Pharma Science Limited64380-24464380-0244-01
TheophyllineTheophylline anhydrous 300 mg/1Tablet, Extended releaseOralPD-Rx Pharmaceuticals, Inc.72789-44172789-0441-01
TheophyllineTheophylline anhydrous 450 mg/1Tablet, Extended releaseOralPD-Rx Pharmaceuticals, Inc.72789-44272789-0442-01
TheophyllineTheophylline anhydrous 300 mg/1Tablet, Extended releaseOralHarman Finochem Limited82638-10582638-0105-02
TheophyllineTheophylline anhydrous 450 mg/1Tablet, Extended releaseOralHarman Finochem Limited82638-10682638-0106-02
TheophyllineTheophylline anhydrous 300 mg/1Tablet, Extended releaseOralZydus Lifesciences Limited70771-178270771-1782-01
TheophyllineTheophylline anhydrous 450 mg/1Tablet, Extended releaseOralZydus Lifesciences Limited70771-178370771-1783-01

All 41 Theophylline NDCs

Other NDCs under ANDA 091586

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091586
ProductStrengthForm · routeLabelerProduct NDC
TheophyllineTheophylline anhydrous 80 mg/15mLSolutionOralATLANTIC BIOLOGICALS CORP.17856-0038
TheophyllineTheophylline anhydrous 80 mg/15mLSolutionOralCranbury Pharmaceuticals, LLC27808-033
TheophyllineTheophylline anhydrous 80 mg/15mLSolutionOralBryant Ranch Prepack71335-2909

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in